speb/financial-data huggingface dataset:
DuPont ROE decomposition for COHU (quarterly period ending 2025-12-31)
ROE: -2.7820871591980345%
Net margin: -18.39810193896752%
Asset turnover: 0.10796496681245427
Equity multiplier (leverage): 1.4006023649225425
EBIT margin: -11.204286999918187%
ROE archetype: Low Return
DuPont ROE decomposition for COHU (quarterly period ending 2026-03-31)
ROE: -1.5526216250292693%
Net margin: -9.645217752699429%
Asset turnover: 0.10098308366481451
Equity multiplier (leverage): 1.5940611064937873
EBIT margin: -8.298499828163589%
ROE archetype: Low Return
DuPont ROE decomposition for COLA.TO (annual period ending 2022-12-31)
ROE: 37.059552389065274%
Net margin: 22.256069202864847%
Asset turnover: 0.463590008947533
Equity multiplier (leverage): 3.5918454270889795
EBIT margin: 28.002046321272438%
Interest burden factor: 0.970436804517522
Tax burden factor: 0.8190142050316618
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COLA.TO (annual period ending 2023-12-31)
ROE: 40.779187922385695%
Net margin: 23.416531887922368%
Asset turnover: 0.4874248031632373
Equity multiplier (leverage): 3.5727972694167285
EBIT margin: 28.62700528915505%
Interest burden factor: 0.9888532600397008
Tax burden factor: 0.8272081531809758
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COLA.TO (annual period ending 2024-12-31)
ROE: 37.93594813152364%
Net margin: 22.628078451371625%
Asset turnover: 0.45603088269316716
Equity multiplier (leverage): 3.6762836497927878
EBIT margin: 29.795371964046662%
Interest burden factor: 0.933247753530167
Tax burden factor: 0.8137704416934128
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COLA.TO (annual period ending 2025-12-31)
ROE: 44.12795948082099%
Net margin: 27.402432156191985%
Asset turnover: 0.4766782502832282
Equity multiplier (leverage): 3.378309216424295
EBIT margin: 31.102813875388495%
Interest burden factor: 1.07289920193146
Tax burden factor: 0.8211651456432054
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COLL (annual period ending 2022-12-31)
ROE: -12.831935619630263%
Net margin: -5.389140242233253%
Asset turnover: 0.39512882293372714
Equity multiplier (leverage): 6.0260672750228395
EBIT margin: 7.181856000758731%
Interest burden factor: -0.8657822863831448
ROE archetype: Low Return
DuPont ROE decomposition for COLL (annual period ending 2023-12-31)
ROE: 24.677597476638148%
Net margin: 8.496436807365285%
Asset turnover: 0.4891321842775581
Equity multiplier (leverage): 5.937994685771242
EBIT margin: 29.45848999677116%
Interest burden factor: 0.4535969477902025
Tax burden factor: 0.6358522704765426
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COLL (annual period ending 2024-12-31)
ROE: 32.615792190405706%
Net margin: 10.957337805586832%
Asset turnover: 0.44992641345484824
Equity multiplier (leverage): 6.615785119486746
EBIT margin: 26.44409920674512%
Interest burden factor: 0.5902947041879016
Tax burden factor: 0.7019519519519519
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COLL (annual period ending 2025-12-31)
ROE: 23.70140824893453%
Net margin: 8.054401479949831%
Asset turnover: 0.4701608980778063
Equity multiplier (leverage): 6.258847501588074
EBIT margin: 22.86209896139601%
Interest burden factor: 0.5190076994631669
Tax burden factor: 0.678802405553936
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COLR.BR (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.098366918154904
ROE archetype: Standard Business
DuPont ROE decomposition for COLR.BR (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 2.0684264782218618
ROE archetype: Standard Business
DuPont ROE decomposition for COLR.BR (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 2.036666704435316
ROE archetype: Standard Business
DuPont ROE decomposition for COLR.BR (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 2.0128096740246533
ROE archetype: Standard Business
DuPont ROE decomposition for CONCORDBIO.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.1093862394578602
ROE archetype: Standard Business
DuPont ROE decomposition for CONCORDBIO.NS (quarterly period ending 2024-12-31)
Net margin: 31.087150039185946%
EBIT margin: 34.67690223822599%
Interest burden factor: 1.194411250708483
Tax burden factor: 0.7505622709518223
ROE archetype: Standard Business
DuPont ROE decomposition for CONCORDBIO.NS (quarterly period ending 2025-03-31)
ROE: 7.744571341094241%
Net margin: 32.65701103414458%
Asset turnover: 0.21132283790868533
Equity multiplier (leverage): 1.1222109898536314
EBIT margin: 40.896191017200465%
Interest burden factor: 1.0440149687638824
Tax burden factor: 0.7648686256498435
ROE archetype: Standard Business
DuPont ROE decomposition for CONCORDBIO.NS (quarterly period ending 2025-06-30)
Net margin: 21.598273620553407%
EBIT margin: 21.384388070647432%
Interest burden factor: 1.3463956993684307
Tax burden factor: 0.7501523876332753
ROE archetype: Standard Business
DuPont ROE decomposition for CONCORDBIO.NS (quarterly period ending 2025-09-30)
ROE: 3.452071435546896%
Net margin: 25.52555579166793%
Asset turnover: 0.1221111253129049
Equity multiplier (leverage): 1.1075142773437243
EBIT margin: 28.373799621545594%
Interest burden factor: 1.222317959018311
Tax burden factor: 0.7359927174268242
ROE archetype: Low Return
DuPont ROE decomposition for CONCORDBIO.NS (quarterly period ending 2025-12-31)
Net margin: 22.911911465046117%
EBIT margin: 28.88528473607281%
Interest burden factor: 1.0738145537711803
Tax burden factor: 0.7386783725780823
ROE archetype: Standard Business
DuPont ROE decomposition for CONCORDBIO.NS (quarterly period ending 2026-03-31)
ROE: 4.406174663968423%
Net margin: 27.229700968720522%
Asset turnover: 0.1459147293644938
Equity multiplier (leverage): 1.1089697579024365
EBIT margin: 30.356882184595413%
Interest burden factor: 1.1524211113311162
Tax burden factor: 0.7783492321745091
ROE archetype: Low Return
DuPont ROE decomposition for COO.V (quarterly period ending 2024-12-31)
Net margin: -107.74159516541204%
Asset turnover: 1.9120471132846766
EBIT margin: -107.71478117801267%
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (quarterly period ending 2025-03-31)
Net margin: -112.99647929535432%
Asset turnover: 0.4417832191588708
EBIT margin: -95.77152645891566%
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (quarterly period ending 2025-06-30)
Net margin: -79.41251008484053%
Asset turnover: 0.7025914226381421
EBIT margin: -73.92252052424895%
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (quarterly period ending 2025-09-30)
Net margin: -17.72496868909487%
Asset turnover: 1.6910832255881596
EBIT margin: -9.807639992272483%
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (quarterly period ending 2025-12-31)
Net margin: 7.842732302274272%
Asset turnover: 3.9201003082457717
EBIT margin: 2.359272860159573%
Interest burden factor: 3.3242158779988746
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (quarterly period ending 2026-03-31)
Net margin: 39.75335800823746%
Asset turnover: 0.8204657105545389
EBIT margin: 39.60861182445568%
Interest burden factor: 1.003654411935043
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for COOT (quarterly period ending 2024-09-30)
ROE: -234.90713377941668%
Net margin: -5.9412336205381715%
Asset turnover: 0.3087940178860114
Equity multiplier (leverage): 128.04148356275488
EBIT margin: -1.9302314436290917%
ROE archetype: Low Return
DuPont ROE decomposition for COOT (quarterly period ending 2024-12-31)
ROE: -277.3869023827139%
Net margin: -3.078679358310849%
Asset turnover: 0.2975268526008038
Equity multiplier (leverage): 302.82750806469704
EBIT margin: 0.13488900513808416%
Interest burden factor: -22.8237976487353
ROE archetype: Low Return
DuPont ROE decomposition for COOT (quarterly period ending 2025-03-31)
Net margin: -5.935784373400091%
Asset turnover: 0.2969786968617139
EBIT margin: -1.4106233698697423%
ROE archetype: Standard Business
DuPont ROE decomposition for COOT (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 7.295497919864855
ROE archetype: Standard Business
DuPont ROE decomposition for COR.L (annual period ending 2021-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for COR.L (annual period ending 2022-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for COR.L (annual period ending 2023-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for COR.L (annual period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for COR.L (annual period ending 2025-12-31)
Asset turnover: 0
Interest burden factor: 3.7804492154971943
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for COUNCODOS.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.520217238258071
ROE archetype: Standard Business
DuPont ROE decomposition for COUNCODOS.NS (quarterly period ending 2024-12-31)
Net margin: 3.1308678259449745%
EBIT margin: 3.835006939341987%
Interest burden factor: 1.0984566258648218
Tax burden factor: 0.7432170542635658
ROE archetype: Standard Business
DuPont ROE decomposition for COUNCODOS.NS (quarterly period ending 2025-03-31)
ROE: 0.3533920859296563%
Net margin: 3.390672782874618%
Asset turnover: 0.07035927338450698
Equity multiplier (leverage): 1.481322411512534
EBIT margin: 5.409021406727829%
Interest burden factor: 1.0487632508833922
Tax burden factor: 0.5977088948787063
ROE archetype: Low Return
DuPont ROE decomposition for COUNCODOS.NS (quarterly period ending 2025-06-30)
Net margin: 3.899548532731377%
EBIT margin: 5.112866817155757%
Interest burden factor: 0.9955849889624724
Tax burden factor: 0.7660753880266076
ROE archetype: Standard Business
DuPont ROE decomposition for COUNCODOS.NS (quarterly period ending 2025-09-30)
ROE: 0.8111868323625815%
Net margin: 3.537456938660086%
Asset turnover: 0.1418037587826852
Equity multiplier (leverage): 1.617119029091109
EBIT margin: 4.898280974171765%
Interest burden factor: 1.0290412876137158
Tax burden factor: 0.7018021081264877
ROE archetype: Low Return
DuPont ROE decomposition for COUNCODOS.NS (quarterly period ending 2025-12-31)
Net margin: 1.5873015873015872%
EBIT margin: 2.2217706428232744%
Interest burden factor: 1.0071138211382114
Tax burden factor: 0.7093844601412714
ROE archetype: Standard Business
DuPont ROE decomposition for COUNCODOS.NS (quarterly period ending 2026-03-31)
ROE: 0.697447234146892%
Net margin: 4.874996599472238%
Asset turnover: 0.08170100973281975
Equity multiplier (leverage): 1.751094626309173
EBIT margin: 8.155825784161703%
Interest burden factor: 1.0033355570380253
Tax burden factor: 0.5957446808510639
ROE archetype: Low Return
DuPont ROE decomposition for COUR (annual period ending 2022-12-31)
ROE: -25.24666162761401%
Net margin: -33.480666569929504%
Asset turnover: 0.5527201964548221
Equity multiplier (leverage): 1.3642831947593852
EBIT margin: -31.92918076356166%
ROE archetype: Low Return
DuPont ROE decomposition for COUR (annual period ending 2023-12-31)
ROE: -17.791082944439484%
Net margin: -18.33910034602076%
Asset turnover: 0.6806806806806807
Equity multiplier (leverage): 1.4252168002142254
EBIT margin: -23.812519660270524%
ROE archetype: Low Return
DuPont ROE decomposition for COUR (annual period ending 2024-12-31)
ROE: -13.101580924098174%
Net margin: -11.44378868576364%
Asset turnover: 0.7506890140817675
Equity multiplier (leverage): 1.5250841714774463
EBIT margin: -15.013674967611918%
ROE archetype: Low Return
DuPont ROE decomposition for COUR (annual period ending 2025-12-31)
ROE: -8.271835212067149%
Net margin: -6.732673267326733%
Asset turnover: 0.7848520955291923
Equity multiplier (leverage): 1.5654042656718838
EBIT margin: -10.336633663366337%
ROE archetype: Low Return
DuPont ROE decomposition for COV.PA (annual period ending 2022-12-31)
ROE: 8.146047382150485%
Net margin: 126.70254674215022%
Asset turnover: 0.03275304635929421
Equity multiplier (leverage): 1.9629529385390876
EBIT margin: 84.32119437383344%
Interest burden factor: 1.6831689648582207
Tax burden factor: 0.8927315430500145
ROE archetype: Standard Business
DuPont ROE decomposition for COV.PA (annual period ending 2023-12-31)
ROE: -11.147484428143086%
Net margin: -115.67876070118224%
Asset turnover: 0.04762172255471096
Equity multiplier (leverage): 2.0235696010084285
EBIT margin: 64.76966979209132%
Interest burden factor: -2.6562185297079557
ROE archetype: Low Return
DuPont ROE decomposition for COV.PA (annual period ending 2024-12-31)
ROE: 1.5935324432657243%
Net margin: 15.47628381027048%
Asset turnover: 0.049454360662322686
Equity multiplier (leverage): 2.0820427030098982
EBIT margin: 62.77538220305762%
Interest burden factor: 0.2758836018483827
Tax burden factor: 0.8936170212765957
ROE archetype: Low Return
DuPont ROE decomposition for COV.PA (annual period ending 2025-12-31)
ROE: 9.960173903708872%
Net margin: 83.08618095852138%
Asset turnover: 0.05893029343180027
Equity multiplier (leverage): 2.034227497182116
EBIT margin: 60.147575041192056%
Interest burden factor: 1.1489995235826584
Tax burden factor: 1.2022390380429149
ROE archetype: Standard Business
DuPont ROE decomposition for COV.V (quarterly period ending 2025-03-31)
ROE: 1.3776552807219142%
Net margin: 5.657010417128045%
Asset turnover: 0.21583772462717404
Equity multiplier (leverage): 1.128304262397811
EBIT margin: 3.71501698926228%
Interest burden factor: 1.522741466184089
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COV.V (quarterly period ending 2025-06-30)
ROE: 0.2169556924238495%
Net margin: 0.7711861805423923%
Asset turnover: 0.2429998619341685
Equity multiplier (leverage): 1.1577259931847164
EBIT margin: -0.9395364092156313%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COV.V (quarterly period ending 2025-09-30)
ROE: 1.178001774955479%
Net margin: 4.1226202753529355%
Asset turnover: 0.2418637195338726
Equity multiplier (leverage): 1.1814133730428402
EBIT margin: 2.828426046471388%
Interest burden factor: 1.4575669321445133
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COV.V (quarterly period ending 2025-12-31)
ROE: 0.44243075095890383%
Net margin: 1.8201437741841167%
Asset turnover: 0.20140366716847005
Equity multiplier (leverage): 1.206902637412588
EBIT margin: 0.7584452598042304%
Interest burden factor: 2.399835387795728
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COV.V (quarterly period ending 2026-03-31)
ROE: 3.9910848482382715%
Net margin: 12.529474571714907%
Asset turnover: 0.2626331855594194
Equity multiplier (leverage): 1.212853931363142
EBIT margin: 10.54185314702142%
Interest burden factor: 1.1885457326120203
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for COVH.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.9870313801721744
ROE archetype: Standard Business
DuPont ROE decomposition for COVH.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.963382347625532
ROE archetype: Standard Business
DuPont ROE decomposition for COVH.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.8491861175283464
ROE archetype: Standard Business
DuPont ROE decomposition for COXG.MC (annual period ending 2022-12-31)
ROE: -14.964586234033533%
Net margin: -11.614085367286052%
Asset turnover: 0.5173549500498287
Equity multiplier (leverage): 2.49052606089957
EBIT margin: -14.068923394958773%
ROE archetype: Low Return
DuPont ROE decomposition for COXG.MC (annual period ending 2023-12-31)
ROE: 52.03272805896207%
Net margin: 6.282255495380694%
Asset turnover: 1.081993662630096
Equity multiplier (leverage): 7.654842940973418
EBIT margin: 11.588472830906728%
Interest burden factor: 0.5147854255825013
Tax burden factor: 1.0530843171780733
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COXG.MC (annual period ending 2024-12-31)
ROE: 26.389078965375663%
Net margin: 8.418000196452747%
Asset turnover: 0.5735632572140301
Equity multiplier (leverage): 5.4655513474274215
EBIT margin: 18.14625479921248%
Interest burden factor: 0.6018749509688555
Tax burden factor: 0.770753770154195
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COXG.MC (annual period ending 2025-12-31)
ROE: 20.956527995778846%
Net margin: 6.038125925769925%
Asset turnover: 0.8129326011808886
Equity multiplier (leverage): 4.269358510886559
EBIT margin: 12.921466630162373%
Interest burden factor: 0.5521690707087171
Tax burden factor: 0.8462881881241698
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPEN.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.003876487100655
ROE archetype: Standard Business
DuPont ROE decomposition for CPEN.SW (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.0083600584254588
ROE archetype: Standard Business
DuPont ROE decomposition for CPEN.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0133986863921145
ROE archetype: Standard Business
DuPont ROE decomposition for CPH.TO (quarterly period ending 2025-03-31)
ROE: 2.4933011535318594%
Net margin: 21.832099176304183%
Asset turnover: 0.07370273618112023
Equity multiplier (leverage): 1.5495144524049331
EBIT margin: 20.584075214244113%
Interest burden factor: 0.7627324171382376
Tax burden factor: 1.3905670376258612
ROE archetype: Low Return
DuPont ROE decomposition for CPH.TO (quarterly period ending 2025-06-30)
ROE: 5.605327535234716%
Net margin: 44.0400567969509%
Asset turnover: 0.08671344294626211
Equity multiplier (leverage): 1.4677993605648676
EBIT margin: 37.29915551901951%
Interest burden factor: 1.2833099579242637
Tax burden factor: 0.9200624512099921
ROE archetype: Standard Business
DuPont ROE decomposition for CPH.TO (quarterly period ending 2025-09-30)
ROE: 4.89037255496216%
Net margin: 42.8660484687914%
Asset turnover: 0.08495195000472448
Equity multiplier (leverage): 1.3429354635864716
EBIT margin: 38.75944829735837%
Interest burden factor: 0.8560514676316848
Tax burden factor: 1.2919210897134805
ROE archetype: Low Return
DuPont ROE decomposition for CPH.TO (quarterly period ending 2025-12-31)
ROE: 11.16031665439435%
Net margin: 108.94581764609595%
Asset turnover: 0.08094483091746685
Equity multiplier (leverage): 1.2655427909733863
EBIT margin: 36.22524144704534%
Interest burden factor: 1.042250338906462
Tax burden factor: 2.8855408627791026
ROE archetype: Standard Business
DuPont ROE decomposition for CPH.TO (quarterly period ending 2026-03-31)
ROE: 4.725629439069967%
Net margin: 49.284286285485805%
Asset turnover: 0.08014337987642085
Equity multiplier (leverage): 1.196419651381909
EBIT margin: 44.742103158736505%
Interest burden factor: 0.8845397676496871
Tax burden factor: 1.2453020812285311
ROE archetype: Low Return
DuPont ROE decomposition for CPHC (quarterly period ending 2025-03-31)
ROE: -0.3572727531077034%
Net margin: -2.2768100643816536%
Asset turnover: 0.11696167460343836
Equity multiplier (leverage): 1.3416199771840254
EBIT margin: 4.943609743447389%
Interest burden factor: -0.7391587434255185
ROE archetype: Low Return
DuPont ROE decomposition for CPHC (quarterly period ending 2025-06-30)
ROE: -0.3912853926404355%
Net margin: -2.089949950637487%
Asset turnover: 0.13784880029998153
Equity multiplier (leverage): 1.3581719553174851
EBIT margin: 2.756449203082345%
Interest burden factor: -1.1078880454265454
ROE archetype: Low Return
DuPont ROE decomposition for CPHC (quarterly period ending 2025-09-30)
ROE: 0.5810482804589073%
Net margin: 2.660611276154604%
Asset turnover: 0.15973676172948573
Equity multiplier (leverage): 1.367180693723709
EBIT margin: 5.738810587188947%
Interest burden factor: 0.6120407670073431
Tax burden factor: 0.7574939800989611
ROE archetype: Low Return
DuPont ROE decomposition for CPHC (quarterly period ending 2025-12-31)
ROE: -0.46439432592222774%
Net margin: -3.1344456695173313%
Asset turnover: 0.1096705443628893
Equity multiplier (leverage): 1.350940305713983
EBIT margin: 3.0961507588514996%
Interest burden factor: -1.2952415060259723
ROE archetype: Low Return
DuPont ROE decomposition for CPHC (quarterly period ending 2026-03-31)
ROE: 0.2023781535715045%
Net margin: 1.2574675040604657%
Asset turnover: 0.11950088710797431
Equity multiplier (leverage): 1.3467771188503823
EBIT margin: 7.577604083160826%
Interest burden factor: 0.342160146683742
Tax burden factor: 0.4849929625516389
ROE archetype: Low Return
DuPont ROE decomposition for CPN.AX (annual period ending 2021-06-30)
ROE: -24.58787385155635%
Equity multiplier (leverage): 1.0178582164163616
ROE archetype: Low Return
DuPont ROE decomposition for CPN.AX (annual period ending 2022-06-30)
ROE: -66.31504218875402%
Equity multiplier (leverage): 1.0409866281128455
ROE archetype: Low Return
DuPont ROE decomposition for CPN.AX (annual period ending 2023-06-30)
ROE: -178.82037261111412%
Equity multiplier (leverage): 1.1510094169185532
ROE archetype: Low Return
DuPont ROE decomposition for CPN.AX (annual period ending 2024-06-30)
ROE: -105.34792747694097%
Equity multiplier (leverage): 1.3011900446891178
ROE archetype: Low Return
DuPont ROE decomposition for CPRX (annual period ending 2022-12-31)
ROE: 27.654191950629283%
Net margin: 38.785171076035354%
Asset turnover: 0.5702499800335437
Equity multiplier (leverage): 1.2503453486939995
EBIT margin: 47.5427515020798%
Interest burden factor: 1.0282900292621615
Tax burden factor: 0.7933517317774234
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CPRX (annual period ending 2023-12-31)
ROE: 20.74961281530491%
Net margin: 17.933019256461513%
Asset turnover: 0.9416655631018369
Equity multiplier (leverage): 1.2287397101853548
EBIT margin: 21.800885978041407%
Interest burden factor: 1.088685895959084
Tax burden factor: 0.7555734253155717
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CPRX (annual period ending 2024-12-31)
ROE: 29.383610948505307%
Net margin: 33.328791582440914%
Asset turnover: 0.7441917481697281
Equity multiplier (leverage): 1.1846791565853558
EBIT margin: 39.68080303578764%
Interest burden factor: 1.1083362374695065
Tax burden factor: 0.757822651123863
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CPRX (annual period ending 2025-12-31)
ROE: 25.486176348177658%
Net margin: 36.3887950369192%
Asset turnover: 0.6024261144835558
Equity multiplier (leverage): 1.1626077650276474
EBIT margin: 43.76618239050305%
Interest burden factor: 1.0998417242743757
Tax burden factor: 0.7559600021162901
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CQD.DE (quarterly period ending 2025-03-31)
ROE: 6.865802553357373%
Net margin: 10.258463778667636%
Asset turnover: 0.09098798309418764
Equity multiplier (leverage): 7.3557158171718156
EBIT margin: 24.463050600655258%
Interest burden factor: 0.5517857142857143
Tax burden factor: 0.7599784250269687
ROE archetype: Standard Business
DuPont ROE decomposition for CQD.DE (quarterly period ending 2025-06-30)
ROE: 7.31230129616043%
Net margin: 10.860090077001308%
Asset turnover: 0.0910019402200679
Equity multiplier (leverage): 7.398948398141355
EBIT margin: 24.4079616446317%
Interest burden factor: 0.5681547619047619
Tax burden factor: 0.7831325301204819
ROE archetype: Standard Business
DuPont ROE decomposition for CQD.DE (quarterly period ending 2025-09-30)
ROE: 6.587245970567625%
Net margin: 9.6255119953189%
Asset turnover: 0.08981766462246953
Equity multiplier (leverage): 7.619356291921113
EBIT margin: 23.77121123464014%
Interest burden factor: 0.5335384615384615
Tax burden factor: 0.7589388696655133
ROE archetype: Standard Business
DuPont ROE decomposition for CQD.DE (quarterly period ending 2025-12-31)
ROE: 7.709377415413768%
Net margin: 11.366811263877656%
Asset turnover: 0.08858768396062046
Equity multiplier (leverage): 7.656094946019398
EBIT margin: 24.659951474156312%
Interest burden factor: 0.584675014907573
Tax burden factor: 0.7883732789393166
ROE archetype: Standard Business
DuPont ROE decomposition for CQD.DE (quarterly period ending 2026-03-31)
ROE: 6.554617807593353%
Net margin: 10.024270059571965%
Asset turnover: 0.08804721926328365
Equity multiplier (leverage): 7.426410829786723
EBIT margin: 23.7037581819519%
Interest burden factor: 0.5671734408935775
Tax burden factor: 0.7456236323851203
ROE archetype: Standard Business
DuPont ROE decomposition for CR1.AX (annual period ending 2022-06-30)
ROE: -48.15238976353494%
Equity multiplier (leverage): 1.019359231638858
ROE archetype: Low Return
DuPont ROE decomposition for CR1.AX (annual period ending 2023-06-30)
ROE: -36.852333018854786%
Equity multiplier (leverage): 1.021088222825606
ROE archetype: Low Return
DuPont ROE decomposition for CR1.AX (annual period ending 2024-06-30)
ROE: -71.46266471153896%
Equity multiplier (leverage): 1.0312901597084252
ROE archetype: Low Return
DuPont ROE decomposition for CR1.AX (annual period ending 2025-06-30)
ROE: -209.9222687760562%
Equity multiplier (leverage): 1.2112106623018957
ROE archetype: Low Return
DuPont ROE decomposition for CRAC (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 8.71972
ROE archetype: Standard Business
DuPont ROE decomposition for CRAC (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 11.174035522346314
ROE archetype: Standard Business
DuPont ROE decomposition for CRAC (quarterly period ending 2025-09-30)
ROE: 0.3824548822756066%
Asset turnover: 0
Equity multiplier (leverage): 17.35883032548504
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CRAC (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0135172644848138
ROE archetype: Standard Business
DuPont ROE decomposition for CRAC (quarterly period ending 2026-03-31)
ROE: -0.15328322141921108%
Asset turnover: 0
Equity multiplier (leverage): 1.0152856460286153
ROE archetype: Low Return
DuPont ROE decomposition for CRAP.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 7.775609678515402
ROE archetype: Standard Business
DuPont ROE decomposition for CRAP.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 7.533099808870263
ROE archetype: Standard Business
DuPont ROE decomposition for CRAP.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 7.156527221074737
ROE archetype: Standard Business
DuPont ROE decomposition for CRCL.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.20732538330494
ROE archetype: Standard Business
DuPont ROE decomposition for CRCL.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.335079072868801
ROE archetype: Standard Business
DuPont ROE decomposition for CRCL.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.8111631376496389
ROE archetype: Standard Business
DuPont ROE decomposition for CRD.V (quarterly period ending 2024-12-31)
ROE: -200.08511631557022%
Asset turnover: 0
Equity multiplier (leverage): 1.6106300820778843
ROE archetype: Low Return
DuPont ROE decomposition for CRD.V (quarterly period ending 2025-03-31)
ROE: -2.0663366437277007%
Asset turnover: 0
Equity multiplier (leverage): 1.5777122701444444
ROE archetype: Low Return
DuPont ROE decomposition for CRD.V (quarterly period ending 2025-06-30)
ROE: 56.66463186043858%
Asset turnover: 0
Equity multiplier (leverage): 1.405207642248466
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRD.V (quarterly period ending 2025-09-30)
ROE: 137.4080153523183%
Asset turnover: 0
Equity multiplier (leverage): 1.0923832922219936
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRD.V (quarterly period ending 2025-12-31)
ROE: -33.45805586503719%
Asset turnover: 0
Equity multiplier (leverage): 1.054965067180305
ROE archetype: Low Return
DuPont ROE decomposition for CRD.V (quarterly period ending 2026-03-31)
ROE: -36.811728869300254%
Asset turnover: 0
Equity multiplier (leverage): 1.0570469363780866
ROE archetype: Low Return
DuPont ROE decomposition for CRDF (annual period ending 2022-12-31)
ROE: -36.39543740537694%
Net margin: -10026.943005181347%
Asset turnover: 0.0033221161707877546
Equity multiplier (leverage): 1.0926060013353018
EBIT margin: -10337.305699481865%
ROE archetype: Low Return
DuPont ROE decomposition for CRDF (annual period ending 2023-12-31)
ROE: -47.07011506002885%
Net margin: -8492.008196721312%
Asset turnover: 0.004933578664294235
Equity multiplier (leverage): 1.1234992787451301
EBIT margin: -9305.737704918032%
ROE archetype: Low Return
DuPont ROE decomposition for CRDF (annual period ending 2024-12-31)
ROE: -59.508278319186836%
Net margin: -6651.6837481698385%
Asset turnover: 0.007638667539018157
Equity multiplier (leverage): 1.1711922351461805
EBIT margin: -7123.133235724744%
ROE archetype: Low Return
DuPont ROE decomposition for CRDF (annual period ending 2025-12-31)
ROE: -71.45406235146528%
Net margin: -7732.040472175378%
Asset turnover: 0.007455649571897356
Equity multiplier (leverage): 1.2395022479877198
EBIT margin: -8256.323777403035%
ROE archetype: Low Return
DuPont ROE decomposition for CRESY (annual period ending 2021-06-30)
ROE: -25.588265782108426%
Net margin: -29.63583005402521%
Asset turnover: 0.2695695481523168
Equity multiplier (leverage): 3.2029704110661927
EBIT margin: 29.878610018008402%
Interest burden factor: 0.9229412683885082
Tax burden factor: -1.0746885959608174
ROE archetype: Low Return
DuPont ROE decomposition for CRESY (annual period ending 2022-06-30)
ROE: 149.978599531473%
Net margin: 65.72663422360702%
Asset turnover: 0.8218498602463237
Equity multiplier (leverage): 2.776485534285564
EBIT margin: 23.552567135250044%
Interest burden factor: 2.8782008030351633
Tax burden factor: 0.9695764374475182
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRESY (annual period ending 2023-06-30)
ROE: 23.803742420307547%
Net margin: 41.21339506060182%
Asset turnover: 0.2504257927807614
Equity multiplier (leverage): 2.3063636927706144
EBIT margin: 13.248752375100631%
Interest burden factor: 0.22799592864413135
Tax burden factor: 13.643830558539205
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRESY (annual period ending 2024-06-30)
ROE: 2.6878767420347804%
Net margin: 15.514421608594905%
Asset turnover: 0.07818862990602427
Equity multiplier (leverage): 2.215797953760102
EBIT margin: 20.348274212260478%
Interest burden factor: 0.3205626674453034
Tax burden factor: 2.3784556873022464
ROE archetype: Low Return
DuPont ROE decomposition for CREX (quarterly period ending 2025-03-31)
ROE: 11.275527284901239%
Net margin: 34.60036983768235%
Asset turnover: 0.14530310041647385
Equity multiplier (leverage): 2.2427519250083696
EBIT margin: -7.417300184918842%
Tax burden factor: 0.9714450533602538
ROE archetype: Standard Business
DuPont ROE decomposition for CREX (quarterly period ending 2025-06-30)
ROE: -6.126818741254025%
Net margin: -13.944742900997698%
Asset turnover: 0.19947337803496526
Equity multiplier (leverage): 2.202619998988417
EBIT margin: -10.214888718342287%
ROE archetype: Low Return
DuPont ROE decomposition for CREX (quarterly period ending 2025-09-30)
ROE: -30.631964466609524%
Net margin: -74.542523940457%
Asset turnover: 0.16886142220158662
Equity multiplier (leverage): 2.4335502220836904
EBIT margin: -14.77197307291173%
ROE archetype: Low Return
DuPont ROE decomposition for CREX (quarterly period ending 2025-12-31)
ROE: -5.529370383397819%
Net margin: -8.214539525939552%
Asset turnover: 0.22534454984786112
Equity multiplier (leverage): 2.987069996482589
EBIT margin: 1.9104552485263993%
Interest burden factor: -1.7286652078774618
ROE archetype: Low Return
DuPont ROE decomposition for CREX (quarterly period ending 2026-03-31)
ROE: -16.520526106018334%
Net margin: -45.63861022755077%
Asset turnover: 0.11302270755339852
Equity multiplier (leverage): 3.2027700278995614
EBIT margin: -37.96183019329582%
ROE archetype: Low Return
DuPont ROE decomposition for CRI.AX (annual period ending 2021-06-30)
ROE: -102.01827252187996%
Equity multiplier (leverage): 1.3896477936157305
ROE archetype: Low Return
DuPont ROE decomposition for CRI.AX (annual period ending 2022-06-30)
ROE: -165.01417636995095%
Equity multiplier (leverage): 1.3281462913203699
ROE archetype: Low Return
DuPont ROE decomposition for CRI.AX (annual period ending 2023-06-30)
ROE: -146.54259077098394%
Equity multiplier (leverage): 1.3123998655641298
ROE archetype: Low Return
DuPont ROE decomposition for CRI.AX (annual period ending 2024-06-30)
ROE: -321.1627686614533%
Equity multiplier (leverage): 2.055309268514479
ROE archetype: Low Return
DuPont ROE decomposition for CRI.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.191320874247703
ROE archetype: Standard Business
DuPont ROE decomposition for CRI.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.4228553229126892
ROE archetype: Standard Business
DuPont ROE decomposition for CRI.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.7935509241053875
ROE archetype: Standard Business
DuPont ROE decomposition for CRLO.PA (annual period ending 2022-12-31)
ROE: 3.3829251908882405%
Net margin: 21.583007470748445%
Asset turnover: 0.025734173915058
Equity multiplier (leverage): 6.090741969974599
Tax burden factor: 0.8031821527659816
ROE archetype: Low Return
DuPont ROE decomposition for CRLO.PA (annual period ending 2023-12-31)
ROE: 2.678189748005342%
Net margin: 18.331564182273105%
Asset turnover: 0.024888014539070257
Equity multiplier (leverage): 5.870182018241722
Tax burden factor: 0.8627888304041395
ROE archetype: Low Return
DuPont ROE decomposition for CRLO.PA (annual period ending 2024-12-31)
ROE: 2.7574498247981216%
Net margin: 19.740439065621246%
Asset turnover: 0.02521909324501966
Equity multiplier (leverage): 5.538872182031966
Tax burden factor: 0.8565575576016564
ROE archetype: Low Return
DuPont ROE decomposition for CRLO.PA (annual period ending 2025-12-31)
ROE: 2.2749943202230014%
Net margin: 16.388924929288738%
Asset turnover: 0.026518934006695145
Equity multiplier (leverage): 5.234482934506167
Tax burden factor: 0.8699449035812673
ROE archetype: Low Return
DuPont ROE decomposition for CROWN.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 3.1229517367644823
ROE archetype: Standard Business
DuPont ROE decomposition for CROWN.NS (quarterly period ending 2025-03-31)
ROE: 5.264119875388602%
Net margin: 29.214804441691584%
Asset turnover: 0.06215886251608388
Equity multiplier (leverage): 2.8988098511586076
EBIT margin: 49.432221115090805%
Interest burden factor: 0.8125737737665026
Tax burden factor: 0.72732758235373
ROE archetype: Standard Business
DuPont ROE decomposition for CROWN.NS (quarterly period ending 2025-06-30)
Net margin: 27.89496682953959%
EBIT margin: 41.80669765224646%
Interest burden factor: 0.895286963131889
Tax burden factor: 0.7452770112502654
ROE archetype: Standard Business
DuPont ROE decomposition for CROWN.NS (quarterly period ending 2025-09-30)
ROE: 2.9902984993416255%
Net margin: 23.072966959150257%
Asset turnover: 0.049473337123955956
Equity multiplier (leverage): 2.619629623583951
EBIT margin: 31.480120911877073%
Interest burden factor: 0.9835628313273096
Tax burden factor: 0.7451864406779661
ROE archetype: Low Return
DuPont ROE decomposition for CROWN.NS (quarterly period ending 2025-12-31)
Net margin: 19.61065694289243%
EBIT margin: 28.773745809563017%
Interest burden factor: 0.8605592347314202
Tax burden factor: 0.7919813785568381
ROE archetype: Standard Business
DuPont ROE decomposition for CROWN.NS (quarterly period ending 2026-03-31)
ROE: 2.863076598994809%
Net margin: 19.064256025884845%
Asset turnover: 0.05415558493596092
Equity multiplier (leverage): 2.77312760812786
EBIT margin: 38.78079633757003%
Interest burden factor: 0.6946700394976256
Tax burden factor: 0.707659873506676
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (annual period ending 2023-01-31)
ROE: -12.254997532663635%
Net margin: -8.133235411174905%
Asset turnover: 0.44588046648390345
Equity multiplier (leverage): 3.3793364949301954
EBIT margin: -8.482462355593075%
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (annual period ending 2024-01-31)
ROE: 3.840426636210581%
Net margin: 2.403458618810658%
Asset turnover: 0.5235225382204838
Equity multiplier (leverage): 3.05216101458927
EBIT margin: -0.6264328411696075%
Tax burden factor: 0.6949778084810402
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (annual period ending 2025-01-31)
ROE: -0.4443418200051414%
Net margin: -0.31783497874355277%
Asset turnover: 0.5151939999340635
Equity multiplier (leverage): 2.713592948805217
EBIT margin: -2.9441342929929606%
Tax burden factor: -0.21456867700293697
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (annual period ending 2026-01-31)
ROE: -4.136932424756036%
Net margin: -3.349227608865743%
Asset turnover: 0.48634943281021853
Equity multiplier (leverage): 2.539717143839163
EBIT margin: -6.095006135696035%
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (quarterly period ending 2024-12-31)
ROE: 1.3618427588246305%
Net margin: 9.959976767516766%
Asset turnover: 0.07438690017583573
Equity multiplier (leverage): 1.8381128841102368
EBIT margin: 9.8811975289086%
Interest burden factor: 1.0956930640162446
Tax burden factor: 0.9199406968124537
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (quarterly period ending 2025-03-31)
ROE: -0.03377427038555062%
Net margin: -0.21806348443082635%
Asset turnover: 0.08254677575239522
Equity multiplier (leverage): 1.8763027450543426
EBIT margin: 12.712914763270652%
Interest burden factor: 0.2043981820847383
Tax burden factor: -0.08391909338688855
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (quarterly period ending 2025-06-30)
ROE: 0.8811954801395474%
Net margin: 5.311743983701881%
Asset turnover: 0.08720898226497865
Equity multiplier (leverage): 1.9022776612378496
EBIT margin: 15.747421586520097%
Interest burden factor: 0.5971857242324192
Tax burden factor: 0.5648306598717491
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (quarterly period ending 2025-12-31)
ROE: 1.5241915594117872%
Net margin: 8.526116624766775%
Asset turnover: 0.09517544901767809
Equity multiplier (leverage): 1.8782930390789239
EBIT margin: 31.120376777825463%
Interest burden factor: 0.6424114766095589
Tax burden factor: 0.42647456166614334
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (quarterly period ending 2026-03-31)
ROE: 2.857990803474517%
Net margin: 16.99369620026442%
Asset turnover: 0.09064015033171305
Equity multiplier (leverage): 1.8554632620790001
EBIT margin: 33.52413218398656%
Interest burden factor: 0.8547315041202571
Tax burden factor: 0.5930626774589991
ROE archetype: Low Return
DuPont ROE decomposition for CSMG3.SA (quarterly period ending 2024-12-31)
ROE: 3.378755748624946%
Net margin: 13.554413545939855%
Asset turnover: 0.1293345338825844
Equity multiplier (leverage): 1.9273543285112789
EBIT margin: 29.622870985589746%
Interest burden factor: 0.543800490327227
Tax burden factor: 0.8414222458761244
ROE archetype: Low Return
DuPont ROE decomposition for CSMG3.SA (quarterly period ending 2025-03-31)
ROE: 5.425046648745655%
Net margin: 20.787673774753674%
Asset turnover: 0.13564286895291408
Equity multiplier (leverage): 1.9239802841950475
EBIT margin: 29.702900171294594%
Interest burden factor: 0.9352032716843819
Tax burden factor: 0.7483435497109726
ROE archetype: Standard Business
DuPont ROE decomposition for CSMG3.SA (quarterly period ending 2025-06-30)
ROE: 3.5483295163357456%
Net margin: 14.619590911478642%
Asset turnover: 0.12473821823987308
Equity multiplier (leverage): 1.945759624446805
EBIT margin: 23.38035453799747%
Interest burden factor: 0.7438624462072899
Tax burden factor: 0.8406040804472519
ROE archetype: Low Return
DuPont ROE decomposition for CSMG3.SA (quarterly period ending 2025-12-31)
ROE: 3.964368169852148%
Net margin: 15.496715908871414%
Asset turnover: 0.12671785486278636
Equity multiplier (leverage): 2.0188148778750032
EBIT margin: 29.10125081515915%
Interest burden factor: 0.6022544817820931
Tax burden factor: 0.8841948375348009
ROE archetype: Low Return
DuPont ROE decomposition for CSMG3.SA (quarterly period ending 2026-03-31)
ROE: 4.32994184807438%
Net margin: 17.29702298021507%
Asset turnover: 0.11049866547142698
Equity multiplier (leverage): 2.2654457587903885
EBIT margin: 25.653259779102356%
Interest burden factor: 0.8417158787843264
Tax burden factor: 0.8010567479756181
ROE archetype: Low Return
DuPont ROE decomposition for CSR (annual period ending 2022-12-31)
ROE: -1.393071977626451%
Net margin: -5.2466538899016815%
Asset turnover: 0.1262557781656528
Equity multiplier (leverage): 2.1030029290814762
EBIT margin: 6.0031318655635015%
Interest burden factor: -1.1447018363506587
ROE archetype: Low Return
DuPont ROE decomposition for CSR (annual period ending 2023-12-31)
ROE: 5.143120106600308%
Net margin: 18.84014710553406%
Asset turnover: 0.1319855078539532
Equity multiplier (leverage): 2.0683123689891723
EBIT margin: 9.332246497441727%
Interest burden factor: 2.018822275075863
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CSR (annual period ending 2024-12-31)
ROE: -1.1575944390410855%
Net margin: -4.095285899847883%
Asset turnover: 0.13592623880618782
Equity multiplier (leverage): 2.079547793010677
EBIT margin: 9.333558124475541%
Interest burden factor: -0.5826183340859641
ROE archetype: Low Return
DuPont ROE decomposition for CSR (annual period ending 2025-12-31)
ROE: 2.632340626986306%
Net margin: 8.391373299910109%
Asset turnover: 0.14253696866095086
Equity multiplier (leverage): 2.200804810291851
EBIT margin: 8.624507604270962%
Interest burden factor: 0.9729683925091094
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CTA.V (annual period ending 2022-12-31)
ROE: 804.083266613291%
Net margin: 502150%
Asset turnover: 0.0003022289384208538
Equity multiplier (leverage): 5.2982385908727005
EBIT margin: -466475%
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTA.V (annual period ending 2023-12-31)
ROE: 24.78573715341378%
Asset turnover: 0
Equity multiplier (leverage): 3.3006135291308256
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTA.V (annual period ending 2024-12-31)
ROE: 3.109212964971766%
Net margin: 3483.3333333333335%
Asset turnover: 0.0004933838594952408
Equity multiplier (leverage): 1.8091330031550827
EBIT margin: -7750.000000000002%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CTA.V (annual period ending 2025-12-31)
ROE: 1.9357388837148861%
Net margin: 1250%
Asset turnover: 0.0008413177624830522
Equity multiplier (leverage): 1.8406732581057375
EBIT margin: -5360%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUE.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.9554043579364397
ROE archetype: Standard Business
DuPont ROE decomposition for CURI (quarterly period ending 2025-03-31)
ROE: 0.5489021956087825%
Net margin: 2.1139827700463885%
Asset turnover: 0.1770046450523155
Equity multiplier (leverage): 1.4669282125404364
EBIT margin: 0.5235255135851558%
Interest burden factor: 4.3924050632911396
Tax burden factor: 0.9193083573487032
ROE archetype: Low Return
DuPont ROE decomposition for CURI (quarterly period ending 2025-06-30)
ROE: 1.452430134220106%
Net margin: 4.123711340206185%
Asset turnover: 0.23198945724326436
Equity multiplier (leverage): 1.51823411172967
EBIT margin: 2.5247212286976644%
Interest burden factor: 1.39375
Tax burden factor: 1.171898355754858
ROE archetype: Low Return
DuPont ROE decomposition for CURI (quarterly period ending 2025-09-30)
ROE: -7.716803215334673%
Net margin: -20.39326760716815%
Asset turnover: 0.23942826215953625
Equity multiplier (leverage): 1.5804297418457258
EBIT margin: -24.462116673021406%
ROE archetype: Low Return
DuPont ROE decomposition for CURI (quarterly period ending 2025-12-31)
ROE: -8.538469345181042%
Net margin: -18.63831044158913%
Asset turnover: 0.2700550400170172
Equity multiplier (leverage): 1.6963723909292858
EBIT margin: -16.60020676414119%
ROE archetype: Low Return
DuPont ROE decomposition for CURI (quarterly period ending 2026-03-31)
ROE: -3.407399804998204%
Net margin: -8.75931666776598%
Asset turnover: 0.20928033570989807
Equity multiplier (leverage): 1.8587648175706881
EBIT margin: -10.184024800474903%
ROE archetype: Low Return
DuPont ROE decomposition for CURR (annual period ending 2022-12-31)
Net margin: -28.334149866388692%
Asset turnover: 0.3456052448534096
EBIT margin: -18.044154117309446%
ROE archetype: Standard Business
DuPont ROE decomposition for CURR (annual period ending 2023-12-31)
Net margin: -27.072928864382305%
Asset turnover: 0.3554100425087146
EBIT margin: -12.479091072164545%
ROE archetype: Standard Business
DuPont ROE decomposition for CURR (annual period ending 2024-12-31)
Net margin: -83.61455261773062%
Asset turnover: 0.37080397296374884
EBIT margin: -58.95448714873037%
ROE archetype: Standard Business
DuPont ROE decomposition for CURR (annual period ending 2025-12-31)
Net margin: -48.742436560914605%
Asset turnover: 0.3557435943892147
EBIT margin: -20.988307268753253%
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (quarterly period ending 2025-01-31)
Net margin: -1.084329479391208%
Asset turnover: 0.5641663988076349
EBIT margin: 1.2519868486946675%
Interest burden factor: -1.5153623188405798
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (quarterly period ending 2025-04-30)
Net margin: 2.2333765721053522%
Asset turnover: 0.565991962282099
EBIT margin: 6.025980862143515%
Interest burden factor: 0.5348474449366694
Tax burden factor: 0.6929538030797947
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (quarterly period ending 2025-07-31)
Net margin: 0.5962573152819951%
Asset turnover: 0.6070523177989543
EBIT margin: 3.8659695745150415%
Interest burden factor: 0.20216535433070867
Tax burden factor: 0.7629016553067186
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (quarterly period ending 2025-10-31)
Net margin: -2.732688930185879%
Asset turnover: 0.5753675368637915
EBIT margin: 0.08717728457642471%
Interest burden factor: -38.829268292682926
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (quarterly period ending 2026-01-31)
Net margin: -3.436113275295552%
Asset turnover: 0.5880120904894457
EBIT margin: -2.112902679448528%
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (quarterly period ending 2026-04-30)
Net margin: 0.16842961757526445%
Asset turnover: 0.6123087002390196
EBIT margin: 3.4837266069975588%
Interest burden factor: 0.10171668807660866
Tax burden factor: 0.4753157290470723
ROE archetype: Standard Business
DuPont ROE decomposition for CUZ (annual period ending 2022-12-31)
ROE: 3.603331992668738%
Net margin: 21.96604966613756%
Asset turnover: 0.10113949605520275
Equity multiplier (leverage): 1.6219278498645024
EBIT margin: 23.6147660339241%
Interest burden factor: 0.9301828201296573
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUZ (annual period ending 2023-12-31)
ROE: 1.8230258148163696%
Net margin: 10.43949611022402%
Asset turnover: 0.10583983511177873
Equity multiplier (leverage): 1.6499247112262816
EBIT margin: 23.566836141162874%
Interest burden factor: 0.4429740185611906
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUZ (annual period ending 2024-12-31)
ROE: 0.9891404982544955%
Net margin: 5.436891164132696%
Asset turnover: 0.104249900526994
Equity multiplier (leverage): 1.7451457135333939
EBIT margin: 20.36584426407457%
Interest burden factor: 0.2669612461744782
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUZ (annual period ending 2025-12-31)
ROE: 0.8618974049161707%
Net margin: 4.1508689737335684%
Asset turnover: 0.1123446059348604
Equity multiplier (leverage): 1.848265356256116
EBIT margin: 22.671903048451625%
Interest burden factor: 0.18308427681888184
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CVE (annual period ending 2022-12-31)
ROE: 23.378882888107583%
Net margin: 8.987668083327529%
Asset turnover: 1.2845227227979739
Equity multiplier (leverage): 2.0250462140708256
EBIT margin: 14.424858914512647%
Interest burden factor: 0.8434119010819164
Tax burden factor: 0.7387469934715383
ROE archetype: Balanced Compounder